Wang Xuan-Yi, Du Lin, Von Seidlein Lorenz, Xu Zhi-Yi, Zhang Ying-Lin, Hao Zhi-Yong, Han Oak-Pil, Ma Jing-Chen, Lee Hye-Jon, Ali Mohammad, Han Chang-Quan, Xing Zhan-Chun, Chen Ji-Chao, Clemens John
International Vaccine Institute, Seoul, South Korea.
Am J Trop Med Hyg. 2005 Aug;73(2):416-22.
In 2002, population- and treatment center-based surveillance was used to study the disease burden of shigellosis in rural Hebei Province in the People's Republic of China. A total of 10,105 children with diarrhea or dysentery were enrolled. Infants were treated most frequently for diarrhea (1,388/1,000/year) followed by children < or = 5 years old (618/1,000/year). Shigellosis was treated most often in children 3-4 years old (32/1,000/year) and people > 60 years of age (7/1,000/year). Fifty-six percent (184 of 331) Shigella isolates were detected in patients who had non-bloody diarrhea. Shigella flexneri was identified in 93% of 306 isolates. The most common S. flexneri serotypes were 1a (34%), X (33%), and 2a (28%). More than 90% of the Shigella isolates were resistant to cotrimoxazole and nalidixic acid, but remained susceptible to ciprofloxacin, norfloxacin, and gentamicin. Widespread resistance to antibiotics adds urgency to the development and use of vaccines to control shigellosis.
2002年,采用基于人群和治疗中心的监测方法,对中华人民共和国河北省农村地区志贺菌病的疾病负担进行了研究。共纳入10105例腹泻或痢疾患儿。婴儿腹泻治疗最为频繁(1388/1000/年),其次是≤5岁儿童(618/1000/年)。志贺菌病在3 - 4岁儿童(32/1000/年)和60岁以上人群(7/1000/年)中治疗最为常见。56%(331例中的184例)的志贺菌分离株在非血性腹泻患者中检出。306株分离株中93%鉴定为福氏志贺菌。最常见的福氏志贺菌血清型为1a(34%)、X(33%)和2a(28%)。超过90%的志贺菌分离株对复方新诺明和萘啶酸耐药,但对环丙沙星、诺氟沙星和庆大霉素仍敏感。对抗生素的广泛耐药增加了开发和使用疫苗来控制志贺菌病的紧迫性。